Psychedelic therapy works.
The brain-state window closes too fast.
Psychedelics induce a powerful state of heightened neuroplasticity — but the window is brief, and outcomes vary wildly. Most of the therapeutic potential goes untapped.
Limited plasticity window
The neuroplastic opening closes before integration consolidates, leaving most of the therapeutic potential locked behind a single session.
Highly variable outcomes
Response varies widely across individuals — shaped by neurobiology, set, setting, and integration. Clinics can't predict, measure, or reinforce what's working.
One platform, one six-step loop.
Prep the brain. Capture the breakthrough. Reinforce the neural signature.
Built across the full care arc.
Each surface implements one phase of the loop — the same EEG-informed baseline travels from session to clinic to client.
-
01
Facilitator PortalLive mission control for every session.Real-time peak tagging · adaptive audio · multi-electrode EEG.
-
02
Clinic DashboardEvery client, every session, every signal.Roster · band-power trends · protocol generation.
-
03
Client AppHealing at home, between every session.Daily 12-min neurofeedback · music-linked recall · longitudinal scores.
We're not pre-product.
We're pre-scale.
The platform is working. The first sessions are on the calendar. The first clinic partner is engaged. What we need now is acceleration.
Working platform across all three surfaces
Facilitator portal, clinic dashboard, and client app — all running on real EEG hardware (Muse Athena), built pre-funding by the founding team. Active development continues toward production grade.
Psilocybin clients signed up for Psio sessions
First clients seeking psilocybin therapy have signed up for Psio-tracked sessions starting this month — the start of real-world outcome data from the platform.
MindSpa Denver ketamine pilot in motion
Verbal commitment from MindSpa, a Denver ketamine therapy clinic — first ketamine-assisted Psio session planned for June.
Conversations with regional healing centers
Active discussions with additional Colorado and Oregon healing centers — building the pipeline behind MindSpa.
Help us turn a working platform
into the category standard.
Psio is the precision neurofeedback layer for regulated psychedelic care — exactly the clinical-support, AI-assisted-integration, and clinical-delivery infrastructure Elephant Gate exists to back.
$150K to bridge the June pilot to seed-ready evidence.
- Harden the platform through the MindSpa pilot and the next 3–5 clinical deployments
- Build the first longitudinal brain-state dataset in psychedelic care
- Position for the seed round behind Pink Elephant and JLS Fund
Operators, co-investors, and the full ecosystem partner reach.
- Elephant Gate's network of practitioners and clinical operators
- Warm intros to institutional co-investors as we structure the seed round
- Psychedelics Today for Psio Academy growth + Prohibition Partners for international market intelligence